Dr. Curtis Miyamoto, Chair of Radiation Oncology at Temple, Elected President of Philadelphia County Medical Society
(Philadelphia, PA) – Curtis Miyamoto, MD, Professor and Chair of the Department of Radiation Oncology at Temple University School of Medicine, has been installed as the 152nd President of the Philadelphia County Medical Society (PCMS). He was elected by his peers and will serve as president of PCMS for one year.
Temple University Hospital Earns American Heart Association’s Get With the Guidelines® -Stroke Gold Plus Quality Achievement Award
(Philadelphia, PA) – Temple University Hospital has earned the American Heart Association/American Stroke Association’s Get With The Guidelines®–Stroke Gold Plus Quality Achievement Award. The award recognizes Temple University Hospital’s commitment and success in implementing a higher standard of stroke care by ensuring that stroke patients receive treatment for at least 24 months according to nationally accepted standards and recommendations.
“This is a great honor for Temple ,” said John N. Kastanis, FACHE, President and CEO of Temple University Hospital. “The minutes after a patient has a stroke are crucial, and Temple has systems and protocols in place to provide excellent care for those patients in a timely manner. This award confirms that those systems and protocols are highly effective in the treatment of our stroke patients.”
Temple Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents Related to Active Ingredient in Marijuana
(Philadelphia, PA) – HIV, the virus that causes AIDS, is notorious for hiding within certain types of cells, where it reproduces at a slowed rate and eventually gives rise to chronic inflammation, despite drug therapy. But researchers at Temple University School of Medicine's Department of Pathology and Laboratory Medicine and Center for Substance Abuse Research (CSAR) recently discovered that synthetic anti-inflammatory substances distantly related to the active ingredient of marijuana may be able to take the punch out of HIV while inside one of its major hideouts – immune cells known as macrophages.
